🔗 Permalink

Inventor profile of:

Guru Reddy

City:

Irvine, California

Country:

United States

Published Applications:

Last publication date:

2022-09-22

Top Assignees for applications by Guru Reddy

The entities that hold a legal rights for patent applications filed by inventor Reddy Guru:

Spectrum Pharmaceuticals, Inc. 15 Irvine, CA United States
The Board of Trustees of the University of Illinois 7 Urbana, IL United States
Board of Trustees University of Illinois 2 Urbana, IL United States
Spectrum Pharmaceuticals, Inc. 1 Henderson, NV United States
Hanmi Pharmaceutical Co., Ltd. 1 , South Korea
Acrotech Biopharma Inc. 1 East Windsor, NJ United States
The Board of Trustees of the University of Illinois 1 Urbana, CA United States
Spectrum Pharmaceuticals, Inc. 1 Irivne, CA United States
The Board of Trustees of the University of Illionis 1 Urbana, IL United States
The Board of Trustees of the University of Illinoise 1 Urbana, IL United States

Recent patent applications by Reddy Guru

Guru Reddy from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-22

US20220296598A1

Human necessities

Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof

#2 | 2022-02-24

US20220056011A1

Chemistry; metallurgy

Crystalline forms of a quinazoline compound and its hydrochloride salts

#3 | 2022-02-10

US20220040180A1

Human necessities

KITS AND METHODS FOR TREATING CANCERS

#4 | 2021-08-26

US20210260064A1

Human necessities

POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF

#5 | 2021-05-20

US20210145834A1

Human necessities

COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF

#6 | 2018-06-28

US20180177783A1

Human necessities

Combination therapy using belinostat and pralatrexate to treat lymphoma

#7 | 2014-04-17

US20140106003A1

Human necessities

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#8 | 2014-03-13

US20140073680A1

Human necessities

Bladder cancer treatment and methods

#9 | 2013-06-13

US20130150649A1

Human necessities

Sensitization of tumor cells to radiation therapy through administration of endothelin agonists

#10 | 2013-04-25

US20130102543A1

Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#11 | 2013-04-25

US20130101552A1

Human necessities

Methods and compositions for contributing to the treatment of cancers

#12 | 2011-12-29

US20110315575A1

Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#13 | 2011-12-22

US20110311481A1

Human necessities

Methods and compositions for contributing to the treatment of cancers

#14 | 2011-11-24

US20110288143A1

Human necessities

Bladder cancer treatment and methods

#15 | 2009-09-03

US20090221615A1

Human necessities

COMBINATION ANTI-CANCER AGENTS

#16 | 2009-06-25

US20090163570A1

Human necessities

BLADDER CANCER TREATMENT AND METHODS

#17 | 2009-06-18

US20090155206A1

Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#18 | 2008-12-25

US20080318846A1

Human necessities

Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists

#19 | 2008-10-16

US20080253994A1

Human necessities

Methods and compositions for contributing to the treatment of cancers

#20 | 2008-07-31

US20080181971A1

Human necessities

Combination Cancer Treatments Comprising Elsamitrucin and Other Agents

#21 | 2007-12-20

US20070293445A1

Chemistry; metallurgy

Stable Elsamitrucin Salts Suitable for Pharmaceutical Formulations

#22 | 2007-08-09

US20070185188A1

Human necessities

BLADDER CANCER TREATMENT AND METHODS

#23 | 2007-02-08

US20070032422A1

Human necessities

METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

#24 | 2006-10-05

US20060223876A1

Human necessities

Indoloquinone Tumor Radiation Sensitization

InventorID:

208955 ⎘